Serum 25-hydroxyvitamin D levels in early and advanced breast cancer.
about
Vitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological EvidenceVitamin D and breast cancer: interpreting current evidencePretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series studyCorrelates of 25-hydroxyvitamin D and breast cancer stage in the Women's Healthy Eating and Living Study.Breast cancer and the immune systemThe association between breast cancer prognostic indicators and serum 25-OH vitamin D levelsVitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) StudyHigher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studiesTranscriptional effects of 1,25 dihydroxyvitamin D(3) physiological and supra-physiological concentrations in breast cancer organotypic culture.Breast cancer associated with primary hyperparathyroidism: a nested case control study.Vitamin D: marker or mechanism of action?Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort studyBreast cancer survival and season of surgery: an ecological open cohort study.Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study.Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer.Vitamin d deficiency in postmenopausal breast cancer survivors.Vitamin D deficiency in newly diagnosed breast cancer patientsPlasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.Prevalence of serum vitamin D deficiency and insufficiency in cancer: Review of the epidemiological literature.Genetic variants in the vitamin D pathway and breast cancer disease-free survival.Vitamin D and its relationship with breast cancer: an evidence based practice paper.A survey on the relationship between serum 25-hydroxy vitamin D level and tumor characteristics in patients with breast cancer.Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors.High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapyOral paricalcitol (19-nor-1,25-dihydroxyvitamin D2) in women receiving chemotherapy for metastatic breast cancer: a feasibility trial.Triple negative breast cancer patients presenting with low serum vitamin D levels: a case series.Review article: vitamin D acquisition and breast cancer risk.Melanoma and vitamin DImpact of lifestyle factors on prognosis among breast cancer survivors in the USA.Relationship between low ultraviolet B irradiance and higher breast cancer risk in 107 countries.Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?Vitamin D deficiency is widespread in cancer patients and correlates with advanced stage disease: a community oncology experience.Vitamin D and Breast Cancer: Latest Evidence and Future Steps.Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer.Prognostic Significance of Serum Vitamin D Levels in Egyptian Females with Breast Cancer
P2860
Q26766256-47C11A61-5C7B-409A-8F27-EB1A8CEE8844Q26824711-74A343EE-A687-430B-858B-0F8C4DCA844BQ31001849-0BA044D3-990F-4120-874E-EF67A5DDD26FQ33697742-C0E02FF8-3045-41E9-A475-3AA03D6F6BC6Q33753043-003D24A5-059C-421D-B81F-896E095EF650Q34153722-6A7D94F9-6D49-4C01-B68A-EA023E4302E8Q34404259-48B6C655-8C88-4C1D-B00E-548E5B7E7B38Q34575016-776A2513-C7EC-4F14-87D7-0663D6B960F5Q34623118-37218BE9-39D6-45E4-A7C8-C0DA3D2BF2A6Q34769281-D039A629-604A-4070-9776-045A0175E039Q34779961-F1CC56EF-2761-45BC-A4BA-BA979E0383E6Q35608695-5D9DC98B-2DED-4E80-B027-0F2405EE775FQ35659818-E8059131-6C57-4CB1-A066-B29B5A1E3844Q35681151-A1927EEB-52F1-4956-9C97-E185D843D212Q35809053-26FB9C45-2BB7-4BCA-B394-4605C2682035Q35876434-9DEDB397-7029-4517-8F81-5490CD750C87Q35967792-4C1EC26A-7F2B-479C-A4F1-419526D85314Q36009017-07869361-6415-40B5-A307-29CB84008D87Q36230495-852E4433-FF1F-454C-BD09-9FCE0B498FE5Q36636336-E18A6BDE-7933-4815-AF0A-302C8EBCEF25Q36699107-736DAD4C-A711-42CB-A7A1-576991BD12C7Q36759573-E6C5CDAD-6F2B-4024-B957-D047799D7BEAQ37063454-EE12B842-CE16-4E53-8CB6-39BE8E089836Q37171282-7ECF66D3-AB01-49B4-AC42-ADE0FDB3B57EQ37269191-6AFF8F4D-3BB6-4B91-9143-451F986FE2D0Q37338384-ED94DAC9-1F24-4E5E-840E-1850BCB4522BQ37368750-20F654E2-3373-41E0-B6C8-C30F0744A0AAQ37849442-66D649FA-5BA8-4970-9963-4340C26E121BQ38042710-27DD6C10-6E19-4D2F-ACE7-08790000CDE1Q42696116-76BCD58B-7F6D-4AAD-9CC2-81BD5A29047EQ43519004-5DA2F8DD-126C-4188-A08F-CEFDC422461AQ43520763-29B5DA70-4A4F-4CDE-AE41-28FC267B89F0Q49419009-31F3B4A1-E0BF-4D30-867E-642D912DF31AQ50571744-0FABAE87-4AD1-4964-83ED-B801DD8D3AC2Q53702177-A191D1CB-8A08-4E3B-80C7-055A930605A4
P2860
Serum 25-hydroxyvitamin D levels in early and advanced breast cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Serum 25-hydroxyvitamin D levels in early and advanced breast cancer.
@ast
Serum 25-hydroxyvitamin D levels in early and advanced breast cancer.
@en
type
label
Serum 25-hydroxyvitamin D levels in early and advanced breast cancer.
@ast
Serum 25-hydroxyvitamin D levels in early and advanced breast cancer.
@en
prefLabel
Serum 25-hydroxyvitamin D levels in early and advanced breast cancer.
@ast
Serum 25-hydroxyvitamin D levels in early and advanced breast cancer.
@en
P2093
P2860
P356
P1476
Serum 25-hydroxyvitamin D levels in early and advanced breast cancer.
@en
P2093
C Palmieri
D Vigushin
T MacGregor
P2860
P304
P356
10.1136/JCP.2006.042747
P407
P577
2006-10-17T00:00:00Z